These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2653922)

  • 41. [Remarks on the drug treatment of demented patients].
    Wettstein A
    Schweiz Arch Neurol Psychiatr (1985); 1985; 136(4):101-6. PubMed ID: 2413531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholinergic toxins and Alzheimer's disease.
    Hanin I
    Ann N Y Acad Sci; 1992 May; 648():63-70. PubMed ID: 1637073
    [No Abstract]   [Full Text] [Related]  

  • 43. [Alzheimer's disease].
    Kurz A; Lauter H
    Dtsch Med Wochenschr; 1987 Jun; 112(24):973-7. PubMed ID: 2885166
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapy of dementia in the aged].
    Kato T; Kameyama M
    Nihon Rinsho; 1985 Jul; 43(7):1455-61. PubMed ID: 3903268
    [No Abstract]   [Full Text] [Related]  

  • 45. The cholinergic system and EEG slow waves.
    Riekkinen P; Buzsaki G; Riekkinen P; Soininen H; Partanen J
    Electroencephalogr Clin Neurophysiol; 1991 Feb; 78(2):89-96. PubMed ID: 1704840
    [No Abstract]   [Full Text] [Related]  

  • 46. Muscarinic agonists for senile dementia: past experience and future trends.
    Gray JA; Enz A; Spiegel R
    Trends Pharmacol Sci; 1989 Dec; Suppl():85-8. PubMed ID: 2694530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A
    Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacologic management of Alzheimer-type dementia.
    Volicer L; Herz LR
    Am Fam Physician; 1985 Jul; 32(1):123-8. PubMed ID: 2861736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term choline treatment of memory-impaired elderly patients.
    Ferris SH; Sathananthan G; Reisberg B; Gershon S
    Science; 1979 Sep; 205(4410):1039-40. PubMed ID: 472728
    [No Abstract]   [Full Text] [Related]  

  • 50. Can drugs improve memory?
    Kent S
    Geriatrics; 1979 Jul; 34(7):77, 80, 83 passim. PubMed ID: 376407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential role of muscarinic agonists in Alzheimer's disease.
    Avery EE; Baker LD; Asthana S
    Drugs Aging; 1997 Dec; 11(6):450-9. PubMed ID: 9413702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alzheimer's dementia: recent developments in cholinergic pharmacology.
    Moss DE; Rodriguez LA
    Tex Med; 1987 Jan; 83(1):32-4. PubMed ID: 3824230
    [No Abstract]   [Full Text] [Related]  

  • 53. What do we know about Alzheimer's disease today? An overview.
    Lauter H
    Dan Med Bull; 1985 Feb; 32 Suppl 1():1-21. PubMed ID: 2859146
    [No Abstract]   [Full Text] [Related]  

  • 54. Retinoic acid as a therapeutic option in Alzheimer's disease: a focus on cholinergic restoration.
    Szutowicz A; Bielarczyk H; Jankowska-Kulawy A; Ronowska A; Pawełczyk T
    Expert Rev Neurother; 2015 Mar; 15(3):239-49. PubMed ID: 25683350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic strategies in Alzheimer's disease.
    Mayeux R
    Neurology; 1990 Jan; 40(1):175-80. PubMed ID: 1967490
    [No Abstract]   [Full Text] [Related]  

  • 56. Satureja bachtiarica ameliorate beta-amyloid induced memory impairment, oxidative stress and cholinergic deficit in animal model of Alzheimer's disease.
    Soodi M; Saeidnia S; Sharifzadeh M; Hajimehdipoor H; Dashti A; Sepand MR; Moradi S
    Metab Brain Dis; 2016 Apr; 31(2):395-404. PubMed ID: 26638718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of survival analysis techniques in evaluating the effect of long-term tacrine (Cognex) treatment on nursing home placement and mortality in patients with Alzheimer's disease.
    Smith F; Talwalker S; Gracon S; Srirama M
    J Biopharm Stat; 1996 Nov; 6(4):395-409. PubMed ID: 8969976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cardinal features of cognitive and noncognitive dysfunction and the differential efficacy of tacrine in Alzheimer's disease patients.
    Talwalker S
    J Biopharm Stat; 1996 Nov; 6(4):443-56. PubMed ID: 8969979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system.
    Sorial ME; El Sayed NSED
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):581-593. PubMed ID: 28188358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.